MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
Titel:
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
Auteur:
Raab, Marc S Engelhardt, Monika Blank, Antje Goldschmidt, Hartmut Agis, Hermine Blau, Igor W Einsele, Hermann Ferstl, Barbara Schub, Natalie Röllig, Christoph Weisel, Katja Winderlich, Mark Griese, Janine Härtle, Stefan Weirather, Johannes Jarutat, Tiantom Peschel, Christian Chatterjee, Manik